EARLIER IDENTIFICATION AND EARLY INTERVENTION FOR CHILDREN WHO ARE DEAF OR HARD OF HEARING
With
Professor Greg Leigh AO, Director
NextSense Institute, Australia &
Conjoint Professor, Macquarie School of Education
Macquarie University, Sydney
RESEARCHER PROFILE
Filmed in Sydney, Australia | June 2025
As Director of NextSense Institute, Professor Leigh is responsible for leading the not-for-profit organisation’s world-class research and education programs and facilities.
Professor Leigh held a variety of positions in the education of children who are deaf or hard of hearing before entering academia. He holds a degree in Special Education from Griffith University, a Master of Science (Speech and Hearing) from Washington University and a PhD in Special Education from Monash University. In 2001, he was made a Fellow of the Australian College of Educators and in 2014, he was invested as an Officer in the Order of Australia (AO) for distinguished services to the deaf and hard of hearing community.
He is a member of the Editorial Board of The Journal of Deaf Studies and Deaf Education and has researched widely on issues related to the early development and education of children who are deaf or hard of hearing.
A former National President of the Education Commission for the World Congress of the World Federation of the Deaf, Professor Leigh has also Chaired the International Steering Committees of both the Asia-Pacific Congress on Deafness (APCD) and the International Congress on Education of the Deaf (ICED).
He has served on several Australian Government consultative committees, including the New South Wales Ministerial Standing Committee on Hearing, the National Neonatal Hearing Screening Working Party, and the Key Scientists Committee of the Hearing Cooperative Research Centre.
For the last 19 years, Professor Leigh has chaired the Australasian Newborn Hearing Screening Committee.
In his spare time, Professor Leigh is an active member/supporter of the Sydney Swans Football Club, and he and his wife enjoy symphonic music. He is also actively involved in the work of the St Vincent de Paul Society as a volunteer for the Vinnie’s Van program.
Source: Supplied
-
Systems genetics to determine risk of developing diabetes complications
Professor Morahan invented the term “Systems Genetics” for the science field that examines how genetic variants can affect whole networks of genes and whole systems; there are now several laboratories and institutes of systems genetics around the world. He also developed the next-generation genetic resource, The Gene Mine, the most powerful of its type in the world, used globally in rapid mapping and identification of genes. Collaborators nationally and internationally have tested The Gene Mine for traits and diseases in which they specialise.
-
Investigating new approaches to target plaque inflammation in atherosclerosis
Associate Professor Peter Psaltis is an Academic Interventional Cardiologist who holds Level 2 NHMRC Career Development and National Heart Foundation Future Leader Fellowships. He has Faculty positions within the University of Adelaide, Central Adelaide Local Health Network (CALHN) and South Australian Health and Medical Research Institute (SAHMRI). Within SAHMRI, he is the Co-Theme Leader of the Lifelong Health, Program Leader of Heart and Vascular Health and Co-director of the Vascular Research Centre in the Lifelong Health Theme.
-
Benefits of prehabilitation ahead of surgery
Dr Matthew Wallen PhD, AES, AEP is a Senior Research Fellow in Cancer Survivorship, the Deputy Lead of the Cancer Survivorship Program, and a Senior Lecturer in Exercise Science and Clinical Exercise Physiology within the College of Nursing and Health Sciences at Flinders University, in South Australia. His clinical interest focuses on improving outcomes for people requiring major surgery, specifically (1) lifestyle interventions, including exercise, nutritional, and psychological support to improve the health and wellbeing of people prior to surgery, termed ‘prehabilitation’, (2) novel physical function assessments aimed at identifying people at risk of treatment-related complications, and (3) implementation of new models of care in cancer.
